Chemotherapy and Delivery in the Treatment of Primary Brain Tumors

By  

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. : 197-211

Bentham Science Publishers

Access to resources Recommend Favorite

Adrenomedullin and Nitric Oxide: Implications for the Etiology and Treatment of Primary Brain Tumors

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 7, 2011-11 ,pp. : 820-833

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa

By Shoji Mamoru   Sun Aiming   Kisiel Walter   Lu Yang   Shim Hyunsuk   McCarey Bernard   Nichols Christopher   Parker Ernest   Pohl Jan   Mosley Cara   Alizadeh Aaron   Liotta Dennis   Snyder James  

Journal of Drug Targeting, Vol. 16, Iss. 3, 2008-04 ,pp. : 185-197

Informa Healthcare

Access to resources Recommend Favorite

A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors

By Chang Susan M.   Kuhn John G.   Ian Robins H.   Clifford Schold S.   Spence Alexander M.   Berger Mitchel S.   Mehta Minesh P.   Pollack Ian   Gilbert Mark   Prados Michael D.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 429-433

Springer Publishing Company

Access to resources Recommend Favorite

Immunologic Diseases and Brain Tumors

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 3, 2011-06 ,pp. : 192-197

Bentham Science Publishers

Access to resources Recommend Favorite